CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $13.99B, above the global median of $1.15B
- FinancialsAltman Z-Score 3.49: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
13.99BUSDvs all stocks (USD)
Trailing P/E
61.95xvs Medical Instruments & Supplies peers
Revenue (TTM)
4.23BUSDvs all stocks (USD)
Profit Margin
5.57%vs Medical Instruments & Supplies peers
Beta
0.8400xvs all stocks
52-Week Change
0.55%vs all stocks
Market Capitalization
13.99BUSDvs all stocks (USD)
Enterprise Value
16.36BUSDvs all stocks (USD)
Trailing P/E
61.95xvs Medical Instruments & Supplies peers
Forward P/E
14.60xvs Medical Instruments & Supplies peers
PEG Ratio
-0.3245xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
3.37xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.73xvs Medical Instruments & Supplies peers
Enterprise to Revenue
3.87xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
18.45xvs Medical Instruments & Supplies peers
Gross Margin
68.00%vs Medical Instruments & Supplies peers
Profit Margin
5.57%vs Medical Instruments & Supplies peers
Operating Margin
-2.87%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
2.52%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
2.85%vs Medical Instruments & Supplies peers
Revenue (TTM)
4.23BUSDvs all stocks (USD)
Revenue per Share (TTM)
21.49USDUpdated Jul 18, 2026Quarterly Revenue Growth
7.90%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
2.77BUSDvs all stocks (USD)
EBITDA (TTM)
896.20MUSDvs all stocks (USD)
Net Income (TTM)
235.80MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
7.90%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
953.00MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
424.28MUSDvs all stocks (USD)
5-Year Average Dividend Yield
0.02%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
200.00KUSDFY2025 · Oct 31, 2025Revenue
4.09BUSDFY2025 · Oct 31, 2025Cost of Goods Sold
1.41BUSDFY2025 · Oct 31, 2025Gross Profit
2.68BUSDFY2025 · Oct 31, 2025Operating Income
682.90MUSDvs all stocks (USD)
Pre-tax Income
566.50MUSDFY2025 · Oct 31, 2025Income Tax Expense
191.60MUSDFY2025 · Oct 31, 2025Net Income
374.90MUSDFY2025 · Oct 31, 2025EBIT
666.50MUSDFY2025 · Oct 31, 2025EBITDA (Income Statement)
1.05BUSDFY2025 · Oct 31, 2025Research & Development
172.20MUSDFY2025 · Oct 31, 2025Selling, General & Administrative
1.63BUSDFY2025 · Oct 31, 2025Non-operating Interest Expense
100.00MUSDFY2025 · Oct 31, 2025EPS (Basic)
1.91USDFY2025 · Oct 31, 2025EPS (Diluted)
1.87USDFY2025 · Oct 31, 2025Basic Shares Outstanding
195.90MSharesFY2025 · Oct 31, 2025Diluted Shares Outstanding
195.90MSharesFY2025 · Oct 31, 2025Net Income from Continuing Operations
374.90MUSDFY2025 · Oct 31, 2025Operating Cash Flow
742.60MUSDFY2025 · Oct 31, 2025Free Cash Flow
380.20MUSDFY2025 · Oct 31, 2025Cash & Cash Equivalents (End of Period)
110.60MUSDFY2025 · Oct 31, 2025Income Tax Paid
100.00MUSDFY2025 · Oct 31, 2025Interest Paid
115.10MUSDFY2025 · Oct 31, 2025Starting Profit (CF Statement)
374.90MUSDFY2025 · Oct 31, 2025Depreciation & Amortization
377.40MUSDFY2025 · Oct 31, 2025Deferred Taxes (CF)
135.20MUSDFY2025 · Oct 31, 2025Stock-based Compensation
70.50MUSDFY2025 · Oct 31, 2025Other Non-cash Items
45.60MUSDFY2025 · Oct 31, 2025Change in Accounts Receivable (CF)
-120.30MUSDFY2025 · Oct 31, 2025Change in Accounts Payable (CF)
8.00MUSDFY2025 · Oct 31, 2025Change in Other Assets/Liabilities
-148.70MUSDFY2025 · Oct 31, 2025Capital Expenditures
-362.40MUSDFY2025 · Oct 31, 2025Net Acquisitions
-10.50MUSDFY2025 · Oct 31, 2025Net Investing Cash Flow
-372.90MUSDFY2025 · Oct 31, 2025Long-term Debt Issuance
3.11BUSDFY2025 · Oct 31, 2025Long-term Debt Payments
-3.21BUSDFY2025 · Oct 31, 2025Net Short-term Debt Issuance
14.20MUSDFY2025 · Oct 31, 2025Common Stock Repurchase
-290.10MUSDFY2025 · Oct 31, 2025Common Dividends Paid
0.00USDFY2025 · Oct 31, 2025Other Financing Charges
-47.10MUSDFY2025 · Oct 31, 2025Net Financing Cash Flow
-417.10MUSDFY2025 · Oct 31, 2025Shares Outstanding
194.91MSharesUpdated Jul 18, 2026Float Shares
193.67MSharesUpdated Jul 18, 2026Shares Short
7.42MSharesUpdated Jul 18, 2026Short Ratio
1.92daysvs all stocks
Short % of Shares Outstanding
4.34%vs all stocks
% Held by Insiders
0.61%vs all stocks
% Held by Institutions
106.74%vs all stocks
Total Cash (MRQ)
138.80MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.7120USDUpdated Jul 18, 2026Total Debt (MRQ)
2.73BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.3309xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.27xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
42.27USDUpdated Jul 18, 2026Total Assets
12.39BUSDvs all stocks (USD)
Total Current Assets
2.11BUSDFY2025 · Oct 31, 2025Total Liabilities
4.16BUSDFY2025 · Oct 31, 2025Total Non-current Assets
10.29BUSDFY2025 · Oct 31, 2025Total Non-current Liabilities
3.04BUSDFY2025 · Oct 31, 2025Total Current Liabilities
1.11BUSDFY2025 · Oct 31, 2025Cash & Cash Equivalents
110.60MUSDFY2025 · Oct 31, 2025Accounts Receivable
829.00MUSDFY2025 · Oct 31, 2025Inventory
846.00MUSDFY2025 · Oct 31, 2025Accounts Payable
300.40MUSDFY2025 · Oct 31, 2025Short-term Debt
47.80MUSDFY2025 · Oct 31, 2025Deferred Revenue
127.90MUSDFY2025 · Oct 31, 2025Other Current Liabilities
426.10MUSDFY2025 · Oct 31, 2025Long-term Debt
2.46BUSDFY2025 · Oct 31, 2025Other Non-current Liabilities
282.80MUSDFY2025 · Oct 31, 2025Common Stock (Book)
21.80MUSDFY2025 · Oct 31, 2025Retained Earnings
7.64BUSDFY2025 · Oct 31, 2025Total Shareholders' Equity
8.24BUSDvs all stocks (USD)
Treasury Stock
995.20MUSDFY2025 · Oct 31, 202552-Week Low
58.89USDUpdated Jul 18, 202652-Week High
89.83USDUpdated Jul 18, 202652-Week Change
0.55%vs all stocks
Beta
0.8400xvs all stocks
50-Day MA
65.39USDUpdated Jul 18, 2026200-Day MA
72.93USDUpdated Jul 18, 2026Avg 10-Day Volume
2.17MSharesUpdated Jul 18, 2026Avg 30-Day Volume
3.32MSharesUpdated Jul 18, 2026Diluted EPS (TTM)
1.18USDUpdated Jul 18, 2026Other Income / Expense
-16.40MUSDFY2025 · Oct 31, 20253 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Multi-Year FCF With Growth And Margin
Three years of positive free cash flow and rising revenue, four of rising equity, and much of its sales turns into cash.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.68Profit Margin: 0.06
Financial Health
Altman Z-Score 3.49: safe zoneNotable
Altman Z-Score: 3.49
High earnings qualityNotable
Earnings Quality Score: 1.15
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $13.99B, above the global median of $1.15BNotable
Market cap (USD): 13,985,646,477Global Median: 1,146,734,693.424
Revenue is $4.23B, above the global median of $520.53MNotable
Revenue (USD): 4,231,000,064Global Median: 520,528,949.311
Levered free cash flow is $424.28M, above the global median of $16.24MNotable
Levered free cash flow (USD): 424,275,008Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Nio Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Carlisle Companies Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Stanley Black & Decker Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Onto Innovation Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Nova Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Solventum Corporation
Tier 1ProductionThroughput-Bound ConversionRule
Bharat Petroleum Corporation Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Polycab India Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Lincoln Electric Holdings Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Power Assets Holdings Limited
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
XPEL, Inc.
3 interpretationsRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthMulti-Year FCF With Growth And Margin
Dexcom Inc.
2 interpretationsRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income Growth
Snap-on Inc.
3 interpretationsRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthMulti-Year FCF With Growth And Margin